Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts
Curr Opin Investig Drugs
.
2001 Oct;2(10):1366-7.
Authors
T J Walsh
1
,
A H Groll
Affiliation
1
Immunocompromised Host Section, National Cancer Institute, Bethesda, MD 20892, USA. walsht@mail.nih.gov
PMID:
11890348
No abstract available
Publication types
Review
MeSH terms
Animals
Aspergillosis / drug therapy*
Aspergillosis / microbiology
Aspergillus / drug effects*
Humans
Immunologic Deficiency Syndromes / drug therapy*
Immunologic Deficiency Syndromes / microbiology